EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review)

Yihuai Tian, Quwu Mushuo, Hui Fan, Hongwei Su, Jianchun Li, Qiong Zhang

International Journal of Molecular Medicine · 19.03.2026 · 57 (5) · 1-16

DOI: 10.3892/ijmm.2026.5804 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 19.03.2026. Verfasst von Yihuai Tian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China. Hauptthemen laut MEDLINE: Pyroptosis, Kidney Diseases, Kidney. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyroptosis, an inflammatory form of lytic programmed cell death intricately linked to innate immunity, is a pivotal driver of renal fibrosis. Its dysregulated activation initiates a self‑amplifying cycle of chronic inflammation and extracellular matrix deposition, ultimately leading to renal failure. The present review integrates current knowledge primarily from preclinical in vivo and in vitro studies with clinical observations to delineate the multifaceted regulatory mechanisms governing renal pyroptosis, with emphasis on molecular triggers and execution pathways. The critical roles of core effectors such as NLRP3 and GSDMD, whose expression levels in patients correlate with fibrosis severity, were highlighted. The article systematically evaluates pharmacological interventions and explores multi‑target synergistic strategies aimed at integrated signaling hubs to circumvent pathway redundancy. Furthermore, advanced therapeutic approaches were discussed, including nanoparticle‑based delivery systems, offering a strategic framework to bridge the gap between bench research and clinical applications in the management of renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisKidney DiseasesKidneyHumansFibrosisAnimalsSignal TransductionNLR Family, Pyrin Domain-Containing 3 ProteinGasdermins

Stichwörter der Autor:innen

crosstalkpyroptosisrenal fibrosissignaling pathwaytherapeutic strategies

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinGasdermins

Autor:innen und Institutionen

  • Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • Department of Nephrology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • Department of Urology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
  • Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.

Zitieren

APA

Tian, Y., Mushuo, Q., Fan, H., Su, H., Li, J., & Zhang, Q. (2026). Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review). International Journal of Molecular Medicine, 57(5), 1-16. https://doi.org/10.3892/ijmm.2026.5804

Vancouver

Tian Y, Mushuo Q, Fan H, Su H, Li J, Zhang Q. Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review). International Journal of Molecular Medicine. 2026;57(5):1-16. doi:10.3892/ijmm.2026.5804

BibTeX
@article{Tian2026,
  author = {Tian, Yihuai and Mushuo, Quwu and Fan, Hui and Su, Hongwei and Li, Jianchun and Zhang, Qiong},
  title = {Targeting pyroptosis in renal fibrosis: From molecular mechanisms to therapeutic horizons (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {57},
  number = {5},
  pages = {1--16},
  doi = {10.3892/ijmm.2026.5804}
}
Kostenlos starten →